Healthcare Stocks Are Looking Better But What About Biotech?

Large cap biopharmacuiticals remain a core holding for growth and value despite political cross-currents on drug pricing.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.